Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cardiotoxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01301040
What this trial is testing

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Who this might be right for
Breast Cancer
Jules Bordet Institute 2
Not applicableLooking for participantsNCT03882580
What this trial is testing

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

Who this might be right for
Cardiovascular ComplicationCardiovascular InsufficiencyCardiac Complication+5 more
Groupe Hospitalier Pitie-Salpetriere 5,000
Not applicableEnded earlyNCT05781672
What this trial is testing

Prediction of Delayed Toxic Cardiomyopathy in Children

Who this might be right for
CardiotoxicityChildhood Cancer
University Hospital, Montpellier 134
Not applicableLooking for participantsNCT06664528
What this trial is testing

Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies

Who this might be right for
Cardiac ToxicityCancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Large-scale testing (Phase 3)UnknownNCT04939857
What this trial is testing

Effect of Trimetazidine on Radiotherapy-induced Heart Damage.

Who this might be right for
Cardiotoxicity
Peking University Third Hospital 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05271162
What this trial is testing

Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines

Who this might be right for
Cardiotoxicity
Maria Sklodowska-Curie National Research Institute of Oncology 220
Not applicableActive Not RecruitingNCT07442578
What this trial is testing

Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial

Who this might be right for
Childhood Cancer SurvivorsCardiotoxicityCardiovascular Diseases+1 more
Dana-Farber Cancer Institute 20
Not applicableUnknownNCT01032278
What this trial is testing

Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Who this might be right for
Cardiac ToxicityUnspecified Adult Solid Tumor, Protocol Specific
M.D. Anderson Cancer Center 597
Not applicableWithdrawnNCT05521178
What this trial is testing

Cardiotoxicities in Patients Receiving BTKi

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT01436604
What this trial is testing

Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging

Who this might be right for
Cancer, BreastLV Dysfunction
Centre Francois Baclesse 19
Post-approval studies (Phase 4)Looking for participantsNCT06183437
What this trial is testing

The STOP-MED CTRCD Trial

Who this might be right for
Heart FailureCardiotoxicityCardiac Toxicity+2 more
Dinesh Thavendiranathan 335
Testing effectiveness (Phase 2)Ended earlyNCT01120171
What this trial is testing

Myocet Plus Endoxan for Older Patients With Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 64
Not applicableUnknownNCT06334445
What this trial is testing

CARDIOCARE Prospective Clinical Study

Who this might be right for
Breast Cancer
European Institute of Oncology 736
Early research (Phase 1)Study completedNCT00530101
What this trial is testing

The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity

Who this might be right for
Breast Cancer
University of Miami 3
Not applicableEnded earlyNCT00728429
What this trial is testing

Aerobic Exercise in Patients Receiving Chemotherapy for Cancer

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityUnspecified Adult Solid Tumor, Protocol Specific
Wake Forest University Health Sciences 1
Not applicableUnknownNCT05454553
What this trial is testing

Efficacity of Deep Inspiration Breath Hold and Intensity-modulated Radiotherapy in Preventing PErfusion Defect for Left Sided Breast Cancer (EDIPE)

Who this might be right for
Breast Cancer
Institut de cancérologie Strasbourg Europe 58
Not applicableLooking for participantsNCT07058454
What this trial is testing

Multicenter Prospective Observational Study of Cardiotoxicity in Patients Receiving Targeted Cancer Therapies

Who this might be right for
Cancer;Cardiovascular;Adverse EventsCancer
Sixth Affiliated Hospital, Sun Yat-sen University 5,000
Not applicableUnknownNCT05992337
What this trial is testing

New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.

Who this might be right for
CardiotoxicityChemotherapy EffectChemotherapy Induced Systolic Dysfunction
Cardiology Prague 200
Very early researchStudy completedNCT03685175
What this trial is testing

Using Hyperpolarized [1-13C]Pyruvate to Detect Cardiotoxicity

Who this might be right for
Breast Neoplasms
University of Texas Southwestern Medical Center 79
Not applicableUnknownNCT03301389
What this trial is testing

Cardiac Magnetic Resonance for Early Detection of Chemotherapy or Radiation Therapy Induced Cardiotoxicity in Breast Cancer (CareBest)

Who this might be right for
Chemotherapy Induced Cardiotoxicity
Yonsei University 2,000
Next Page